The effects of LDL reduction and HDL augmentation on physiologic and inflammatory markers
Authors:
- Richard H. KarasRKRichard H. Karas
- 1 July 2003
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Cardiology
- Vol. 18 (4) , 295-300
Abstract
Cholesterol plays an important role in atherogenesis. Oxidized low-density lipoprotein cholesterol is harmful to arteries whereas high-density lipoprotein cholesterol appears to have beneficial properties on vascular function. There is increasing evidence that inflammation is also involved in the atherogenic process. Inflammation accelerates atherosclerosis and promotes thrombogenesis, and inflammatory biomarkers have been correlated with cardiovascular risk. There is now evidence that lowering low-density lipoprotein and raising high-density lipoprotein cholesterol have beneficial effects on inflammation that might contribute to the reduction in clinical cardiovascular events with currently available lipid-altering therapies. New therapeutic strategies are being designed to inhibit specific aspects of the inflammatory system that contribute to the initiation and progression of atherosclerosis.Keywords
This publication has 64 references indexed in Scilit:
- Inflammation and AtherosclerosisCirculation, 2002
- Simvastatin and Niacin, Antioxidant Vitamins, or the Combination for the Prevention of Coronary DiseaseNew England Journal of Medicine, 2001
- A major role for VCAM-1, but not ICAM-1, in early atherosclerosisJournal of Clinical Investigation, 2001
- Effect of Statins on Risk of Coronary DiseaseJAMA, 1999
- Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol LevelsJAMA, 1998
- Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory DiseasesNew England Journal of Medicine, 1997
- High-Density Lipoproteins Inhibit Cytokine-Induced Expression of Endothelial Cell Adhesion MoleculesArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- HDL cholesterol predicts coronary heart disease mortality in older persons1995
- Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery diseaseJACC, 1992
- High density lipoprotein cholesterol and mortality. The Framingham Heart Study.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1988